| Final Research Plan: PrEP for HIV Prevention |
|
| U.S. Preventive Services Task Force Announces Appointment of Four New Members |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Prediabetes and Type 2 Diabetes in Youth |
|
| Final Recommendation Statement: Screening and Interventions to Prevent Dental Caries in Children |
|
| Final Research Plan: Serologic Screening for Genital Herpes |
|
| Final Research Plan: Screening for Osteoporosis |
|
| 2021 Report to Congress on Evidence Gaps |
|
| USPSTF Article on Actions to Mitigate Systemic Racism in Clinical Preventive Services |
|
| Public Comment on Draft Research Plan: PrEP for HIV Prevention |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Chronic Obstructive Pulmonary Disease |
|
| Public Comment on Draft Research Plan: Screening for Cervical Cancer |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Glaucoma |
|
| Public Comment on Draft Recommendation Statement and Evidence Review: Screening for Impaired Vision |
|
| U.S. Preventive Services Task Force Publishes Article Addressing Sex and Gender in Primary Care Prevention |
|
| Final Research Plan: Folic Acid to Prevent Neural Tube Defects |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Eating Disorders |
|
| Public Comment on Draft Recommendation Statement, Draft Evidence Review, and Draft Modeling Report: Aspirin Use to Prevent Cardiovascular Disease |
|
| Final Recommendation Statement: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality |
|
| Final Recommendation Statement: Screening for Chlamydia and Gonorrhea |
|
| Final Research Plan: Screening for Hypertensive Disorders of Pregnancy |
|
